MacroGenics

IPO

Developing innovative antibody-based cancer therapeutics

Public · Rockville, United States · Founded 2000 · $100.5M raised

Employees
201–500
Founded
2000
Business Model
B2B
Total Funding
$100.5M
Last Round
$45.0M Series CSep 2008
Rounds
4
Type
Public

About

MacroGenics is a Rockville, Maryland-based clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. Founded in 2000, the company has built proprietary technology platforms for antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and next-generation T-cell engagers, and has developed three FDA-approved therapies. MacroGenics maintains strategic collaborations with companies such as Incyte, Gilead, and Sanofi, and operates additional offices in South San Francisco, California.

Summary

MacroGenics is a Biotech company based in Rockville, United States, founded in 2000. It has raised $100.5M in total across 4 rounds, most recently a $45.0M Series C round in Sep 2008. Investors include Alta Partners, TPG (Growth/Rise) and Clarus Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOOct 2013
$92.0M

Sign up to see all 5 rounds

Series C through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MacroGenics on Indexed.vc
<a href="https://indexed.vc/companies/macrogenics"><img src="https://indexed.vc/api/badge/company/macrogenics" alt="MacroGenics on Indexed.vc" width="260" height="76" /></a>